共 9 条
[1]
Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Robinson K, Mayer EL, Miller DP, et al. Circulation . 1995
[2]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[3]
Hyperhomocysteinemia: an additional cardiovascular risk factor. Fanapour PC, Yug B, Kochar MS. Wisconsin Medical Journal . 1999
[4]
Modification of a high-performance liquid chromatographic method for assay of homocysteine in human plasma. Cornwell PE, Morgn SL, Vaughn WH, et al. Journal of Chromatography . 1993
[5]
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Selhub J, Jacques PF, Wilson PW, et al. The Journal of The American Medical Association . 1993
[6]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[7]
HighertotalplasmahomocysteineinvitaminB12 deficiencythaninheterozygosityforhomocystinuriaduetocystathioninebeta synthasedeficiency. BrattstromL,IsraelssonB,LindgardeF ,etal. Metabolism . 1988
[8]
Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Okada E, Oida K, Tada H, et al. Diabetes Care . 1999
[9]
Homocysteineinducessynthesisofaserineelastaseinarterialsmoothmusclecellfrommulti organdonors. JourdheuilRahmaniD,RollandpH,RossetE ,etal. Cardiovascular Research . 1997